切换至 "中华医学电子期刊资源库"

中华肝脏外科手术学电子杂志 ›› 2023, Vol. 12 ›› Issue (04) : 440 -443. doi: 10.3877/cma.j.issn.2095-3232.2023.04.015

临床研究

肝门空肠吻合术在肝门部胆管癌根治术中的应用价值
陈雪岩, 孟兴凯()   
  1. 010050 呼和浩特,内蒙古医科大学研究生院;010050 呼和浩特,内蒙古医科大学附属医院肝胆外科
    010050 呼和浩特,内蒙古医科大学附属医院肝胆外科
  • 收稿日期:2023-02-21 出版日期:2023-08-10
  • 通信作者: 孟兴凯
  • 基金资助:
    内蒙古医科大学附属医院重大课题(NYFYZD2014005)

Application value of portojejunal anastomosis in radical resection of hilar cholangiocarcinoma

Xueyan Chen, Xingkai Meng()   

  1. Graduate School of Inner Mongolia Medical University, Hohhot 010050, China; Department of Hepatobiliary Surgery, the Affiliated Hospital of Inner Mongolia Medical University, Hohhot 010050, China
    Department of Hepatobiliary Surgery, the Affiliated Hospital of Inner Mongolia Medical University, Hohhot 010050, China
  • Received:2023-02-21 Published:2023-08-10
  • Corresponding author: Xingkai Meng
引用本文:

陈雪岩, 孟兴凯. 肝门空肠吻合术在肝门部胆管癌根治术中的应用价值[J]. 中华肝脏外科手术学电子杂志, 2023, 12(04): 440-443.

Xueyan Chen, Xingkai Meng. Application value of portojejunal anastomosis in radical resection of hilar cholangiocarcinoma[J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2023, 12(04): 440-443.

目的

探讨肝门空肠吻合术在肝门部胆管癌根治术中的应用价值。

方法

回顾性分析2011年12月至2021年12月在内蒙古医科大学附属医院治疗的8例肝门部胆管癌患者临床资料。患者均签署知情同意书,符合医学伦理学规定。其中男5例,女3例;年龄45~69岁,中位年龄58岁。Bismuth-Corlette分型:Ⅱ型1例,Ⅲa 2例,Ⅲb 1例,Ⅳ型4例。患者行肝门部胆管癌根治术,胆道重建方式为肝门空肠吻合术。观察患者手术情况及术后并发症情况。

结果

8例患者均手术成功,无围手术期死亡。R0切除率为6/8。平均手术时间(245±37)min,术中出血量(350±100)ml,术后首次通气时间(2.5±0.7)d,术后住院时间(18±9)d。术后发生并发症2例,其中1例为胆漏,经充分引流、抗感染等保守治疗后痊愈;1例为肺部感染,经抗炎等治疗后痊愈。术后随访3周~24个月,1例患者术后6个月发生反流性食管炎,经保守治疗后症状减轻。1例患者因多器官功能衰竭于术后12个月死亡,1例患者因肿瘤腹腔转移于术后12个月死亡,2例患者因广泛肝内转移于术后16~24个月死亡。

结论

肝门空肠吻合术拓宽了肝门部胆管癌根治术的适应证,可提高根治性切除率、胆道重建成功率,降低术后胆漏发生率,且手术操作简单、易行、安全,尤其对多个肝管开口、内径较细、肝管开口相距较远甚至缩在肝内的患者更能显示出其优势。

Objective

To evaluate the application value of portojejunal anastomosis (Kasai procedure) in radical resection of hilar cholangiocarcinoma.

Methods

Clinical data of 8 patients with hilar cholangiocarcinoma treated in the Affiliated Hospital of Inner Mongolia Medical University from December, 2011 to December, 2021 were retrospectively analyzed. The informed consents of all patients were obtained and the local ethical committee approval was received. Among them, 5 patients were male and 3 female, aged from 45 to 69 years, with a median age of 58 years. According to Bismuth-Corlette classification, 1 casewas classified as Bismuth-Corlette type Ⅱ, 2 cases of type Ⅲa, 1 case of type Ⅲb and 4 cases of type Ⅳ.All patients underwent radical resection of hilar cholangiocarcinoma, and biliary reconstruction was performed by using Kasai procedure. Surgical conditions and postoperative complications were observed.

Results

All 8 patients successfully underwent surgery. No perioperative death occurred. R0 resection rate was 6/8. The average operation time was (245±37) min, intraoperative blood loss was (350±100) ml, postoperative time to first flatus was (2.5±0.7) d, and the length of postoperative hospital stay was (18±9) d, respectively. Postoperative complications occurred in 2 cases, including 1 case of bile leakage who was cured after conservative treatment, such as adequate drainage and anti-infection. 1 case with pulmonary infection recovered after anti-inflammatory treatment. During postoperative follow-up from 3 weeks to 24 months,1 patient developed reflux esophagitis at postoperative 6 months, and relevant symptoms were relieved after conservative treatment. 1 patient died of multiple organ failure at 12 months after operation, 1 patient died of abdominal metastasis of tumor at postoperative 12 months, and 2 patients died of extensive intrahepatic metastases from postoperative 16 to 24 months, respectively.

Conclusions

Kasai procedure can extend the indications for radical resection of hilar cholangiocarcinoma, elevate the radical resection rate and success rate of biliary reconstruction and reduce the incidence of postoperative bile leakage. It is a simple, convenient and safe procedure, especially for patients with multiple hepatic duct openings, small internal diameter, distant hepatic duct openings or even shrinkage in the liver.

[1]
Flemming JA, Zhang-Salomons J, Nanji S, et al. Increased incidence but improved median overall survival for biliary tract cancers diagnosed in Ontario from 1994 through 2012: a population-based study[J]. Cancer, 2016, 122(16):2534-2543.
[2]
Mizuno T, Ebata T, Nagino M. Advanced hilar cholangiocarcinoma: an aggressive surgical approach for the treatment of advanced hilar cholangiocarcinoma: perioperative management, extended procedures, and multidisciplinary approaches[J]. Surg Oncol, 2020(33):201-206.
[3]
Cillo U, Fondevila C, Donadon M, et al. Surgery for cholangiocarcinoma[J]. Liver Int, 2019, 39 Suppl 1(Suppl Suppl 1):143-155.
[4]
王向, 张永杰. 肝门部胆管癌临床认知的争议与焦点[J]. 中华外科杂志, 2020, 58(4):284-288.
[5]
Bednarsch J, Czigany Z, Heise D, et al. Leakage and stenosis of the hepaticojejunostomy following surgery for perihilar cholangiocarcinoma[J]. J Clin Med, 2020, 9(5):1392.
[6]
Zhang Y, Zhao J, Chai S, et al. Reliable reconstruction of the complex high-location bile duct injury: a novel hepaticojejunostomy[J]. BMC Surg, 2019, 19(1):176.
[7]
Wen Z, Liang H, Liang J, et al. Evaluation of the learning curve of laparoscopic choledochal cyst excision and Roux-en-Y hepaticojejunostomy in children: CUSUM analysis of a single surgeon's experience[J]. Surg Endosc, 2017, 31(2):778-787.
[8]
胡海洁, 靳艳文, 林圯昕, 等. 肝门部胆管癌肿瘤直径及相关预后指标对患者预后的影响因素分析[J]. 中华消化外科杂志, 2018, 17(3):266-272.
[9]
Razumilava N, Gores GJ. Cholangiocarcinoma[J]. Lancet, 2014, 383(9935):2168-2179.
[10]
董家鸿, 冯晓彬. 精准外科时代的肝门部胆管癌治疗[J]. 中华消化外科杂志, 2019, 18(4):307-310.
[11]
张哲栋, 张大方, 朱卫华, 等. 肝门-空肠吻合在肝门部胆管癌胆道重建中的应用分析[J]. 中华普通外科杂志, 2020, 35(2):89-91.
[12]
中华医学会外科学分会胆道外科学组, 解放军全军肝胆外科专业委员会. 肝门部胆管癌诊断和治疗指南(2013版)[J]. 中华外科杂志, 2013, 51(10):865-871.
[13]
姜洪池, 谷明旗. 胆肠吻合方式的合理选择和技术要点[J]. 中华消化外科杂志, 2017, 16(4):345-348.
[14]
Li QJ, Zhou ZG, Lin XJ, et al. Clinical practice of basin-shaped hepaticojejunostomy following hilar resection of stageⅢ/Ⅳ hilar cholangiocarcinoma[J]. BMC Gastroenterol, 2019, 19(1):99.
[15]
Petroianu A, Alberti LR, Sabino KR. Omega hepatojejunostomy and hepatic haemostasis using the electrocautery greased with lidocaine gel[J]. Chirurgia, 2020, 115(3):380-384.
[16]
Hwang S, Ha TY, Song GW, et al. Cluster hepaticojejunostomy with radial spreading anchoring traction technique for secure reconstruction of widely opened hilar bile ducts[J]. Korean J Hepatobiliary Pancreat Surg, 2016, 20(2):66-70.
[17]
吴松, 刘振忠, 李筱倩. 肝圆韧带间置肠肝吻合术在肝门区肿瘤外科中的临床应用价值[J]. 中国普通外科杂志, 2019, 28(7):833-839.
[18]
李晓斌, 冯啸, 谢云亮, 等. Kasai手术对胆道闭锁患儿肝移植疗效的影响[J/OL]. 中华肝脏外科手术学电子杂志, 2022, 11(2):149-153.
[19]
中华医学会外科学分会. 腹腔镜肝胆外科手术缝合技术与缝合材料选择中国专家共识(2021版)[J]. 中国实用外科杂志, 2021, 41(5):481-488.
[20]
周存才, 魏小勇, 张长和, 等. 肝圆韧带间置肝肠吻合术28例报告[J]. 中华外科杂志, 2018, 56(6):471-473.
[1] 范伟强, 林师佈, 孙传伟, 宋奇锋, 李望, 符誉, 陈艾. 不同切除范围的Bismuth-Corlette Ⅲ、Ⅳ型腹腔镜肝门部胆管癌手术临床对比分析[J]. 中华普外科手术学杂志(电子版), 2023, 17(04): 423-426.
[2] 宋铭杰, 韩青雷, 李佳隆, 邵英梅. 内镜下晚期肝外胆管恶性肿瘤消融治疗研究现况[J]. 中华普外科手术学杂志(电子版), 2023, 17(03): 340-342.
[3] 潘冰, 吕少诚, 赵昕, 李立新, 郎韧, 贺强. 淋巴结清扫数目对远端胆管癌胰十二指肠切除手术疗效的影响[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 608-612.
[4] 田驹, 孙伯洋, 杨荣华, 赵向前. 术中意外发现肝外胆管绒毛管状腺瘤的外科处理经验:附两例报道并文献复习[J]. 中华肝脏外科手术学电子杂志, 2023, 12(05): 567-571.
[5] 李斌奎. 不可切除肝内胆管细胞癌的转化治疗[J]. 中华肝脏外科手术学电子杂志, 2023, 12(05): 511-516.
[6] 吴周宇, 周宝勇, 李明. 基于PSM分析腹腔镜肝门部胆管癌根治术安全性[J]. 中华肝脏外科手术学电子杂志, 2023, 12(04): 384-388.
[7] 王健东, 全志伟. 重视胆道恶性肿瘤化疗联合靶向免疫的综合治疗[J]. 中华肝脏外科手术学电子杂志, 2023, 12(02): 125-130.
[8] 李卓群, 任冯刚, 王荣峰, 张东, 耿智敏, 吕毅, 仵正. 胆管癌局部治疗技术应用进展[J]. 中华肝脏外科手术学电子杂志, 2023, 12(02): 153-156.
[9] 单季军, 李相成. 肝门部胆管癌术前减黄及其对手术安全性的影响[J]. 中华肝脏外科手术学电子杂志, 2023, 12(02): 157-161.
[10] 莫建涛, 杨沛泽, 曹瑞奇, 马清涌, 王铮, 仵正, 周灿灿. 基于生物信息学分析构建肝内胆管细胞癌患者铁死亡相关lncRNA预后模型[J]. 中华肝脏外科手术学电子杂志, 2023, 12(02): 185-189.
[11] 李杰, 任加强, 马坚, 王铮, 马清涌, 仵正. 血栓弹力图测定对远端胆管癌胰十二指肠切除术后出血的预测价值[J]. 中华肝脏外科手术学电子杂志, 2023, 12(02): 211-215.
[12] 杨传鑫, 王伟, 王坚. 残余左肝管内乳头状黏液瘤一例报告[J]. 中华肝脏外科手术学电子杂志, 2023, 12(02): 236-238.
[13] 俞阳, 陶鹏先, 王博方, 汪学艳, 张爱群, 陈昊. 胆管癌手术治疗策略[J]. 中华肝脏外科手术学电子杂志, 2022, 11(06): 551-554.
[14] 房炯泽, 杨勇, 叶莹鹏, 朱宏达, 吴胜东, 陆才德. 肝门部胆管癌术后患者预后影响因素:单中心160例分析[J]. 中华肝脏外科手术学电子杂志, 2022, 11(06): 619-624.
[15] 陶晨洁, 陈熙昀, 娄成, 魏炜, 杨光, 董雨龙, 曾添美, 尚佩沛, 袁振刚. 术后辅助化疗对可切除胆道恶性肿瘤的疗效分析[J]. 中华肝脏外科手术学电子杂志, 2022, 11(04): 390-394.
阅读次数
全文


摘要